PALM BEACH, Florida, February 20, 2018 /PRNewswire/ --
MarketNewsUpdates.com News Commentary
Themassive growth of the CBD-based product market continues to be one of the most active opportunities in the multi-billion dollar legal marijuana/cannabis markets, as experts are currently forecasting the CBD segment alone to grow to $2.1
Marijuana Company of America, Inc. (OTC: MCOA), an innovative hemp and cannabis corporation, is pleased to announce the release of hempSMART™ Full Spectrum Pet Drops formulated for cats and dogs. Each bottle of hempSMART Full Spectrum Pet Drops is formulated with 250mg of full spectrum non-psychoactive Cannabidiol (CBD) derived from industrial hemp. The new specially formulated product contains naturally occurring CBD derived from hemp seed oil, full spectrum hemp extract, fractionated coconut oil, and a rich bacon flavor. Read this and more news for MCOA at http://www.marketnewsupdates.com/news/mcoa.html
Donald Steinberg, MCOA's CEO said, "Our new hempSMART product is a natural option for pet owners who care about supporting their animals' healthy energy levels as well as optimizing their health. Our hempSMART product line will continue to expand to other popular areas of consumer interest to give our affiliates what they need to succeed."
In reviewing pet supplement trends for 2017, Watson, Inc.'s Mona Hollums observed that natural pet supplement sales nearly doubled between 2008 and 2014. With the increasing focus on pet health, the market for pet supplements is projected to show significant and continuing expansion. Projections show that U.S. retail sales of pet supplements and nutraceuticals treats will grow 3%-5% annually, bringing the market to $1.6 billion. Globally, the pet supplement market is also expected to grow even further. Between 2016-2020, sales are projected to increase over 5% and will continue to yield lucrative investment payouts.
In the industry developments and happenings in the market this week include:
Medical Marijuana Inc. (OTC: MJNA) recently announced it has garnered national news coverage on globally-recognized lifestyle website POPSUGAR. A February 4, 2018, article on the POPSUGAR website entitled "14 of the Best CBD Products We're Obsessed With - You Need to Try These ASAP" showcases Medical Marijuana, Inc.'s Cannabis Beauty Defined CBD Anti-Aging Serum and talks about how the product is like a "miracle syrup" for the face and body that provides moisture to patches of dry and inflamed skin. This leading lifestyle website, which boasts an audience of over three billion global monthly views, is targeted predominately at millennial women and is a trusted source for fashion, beauty and fitness tips as well as beauty product reviews.
mCig, Inc. (OTCQB: MCIG), an innovative biotech company, which focuses on cannabis-industrial hemp, cannabinoid research, and development, nutraceuticals and pharmaceuticals, also recently announced plans to launch an innovatively advanced hemp CBD-based formula for pets. Doctor of Bioengineering and Cardiology at Mt. Sinai Medical Center, Arkady Uryash, will be leading this new initiative in the rapidly expanding sixty-billion-dollar CBD pet industry market. "CBD-based pet products are seeing heightened demand across the globe. Trial studies have shown that CBD oils can help reduce anxiety, inflammation, and chronic pain while boosting the pet's immune system," Says Arkady Uryash, MD, Ph.D. at Biomedical Research Institute, Mt Sinai Medical Center. "Results have demonstrated rapid positive results in improving condition of pets suffering from these ailments, which is one of the many reasons pet owners are eager to obtain CBD wellness products supported by science and from reputable and trustworthy companies."
PotNetwork Holding Inc. (OTC: POTN) recently announced its subsidiary, Diamond CBD, Inc., has successfully launched a new product line, Meds BioTech, which expands the Company's product marketing and distribution into health-focused distribution channels, such as vitamin shops, health product stores, gyms, chiropractic offices and physicians' offices, which the Company regards as a new industry sector for the distribution of its products. Dr. Richard Goulding, CEO, stated, "We have designed this new product line, Meds BioTech, to appeal to health-conscious consumers and health-focused distribution channels, while adding under this new brand such new formulations as 'CBD & Turmeric' capsules." He added, "By creating these specially-designed products formulated and packaged to meet the needs of this sector, we believe we will carve out in 2018 a strong presence in, and sizable incremental revenue source from these new distribution channels. We believe the result will be a significant spike in our consumer awareness, brand preference and distribution footprint."
Rocky Mountain High Brands Inc. (OTCQB: RMHB) recently announced an update from its Chairman, President & Chief Executive Officer, Michael Welch, on the Company's Master Manufacturing Agreement with CBD Alimentos SA de CV ("Client"). Mr. Welch stated, "In January, we amended the agreement with our Client at their request to switch from our Rocky Mountain High functional beverages with hemp seed extract to a new formulation of our Rocky Mountain High functional beverages with water soluble cannabidiol ('CBD'), containing a non-detectable level of 0.00% THC (the compound that creates a 'high'). With an agreement worth an estimated $7.2 million, we believe that this represents one of the largest single orders of CBD-infused beverages in the industry*. Rocky Mountain High Brands will be one of the first companies to infuse a functional beverage with CBD in a can, which affirms our trailblazer status. Migrating from a hemp-based product to a CBD-infused offering demonstrates our Client's confidence in Rocky Mountain High Brands' product quality, capabilities, flexibility, and leadership status." Mr. Welch concluded, "In addition to our CBD-infused beverages, we are also researching other products to present to our Client to enhance their portfolio. As demonstrated by our recent HEMPd product line announcement, we are evolving into a more diverse brand in 2018, which will provide the Company different sources of revenue. This private label agreement is a very important step in our diversification. Properly executing it is a top priority for the Company at this time."
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty four hundred dollars for news coverage of the current press release issued by Marijuana Company of America, Inc. by the company. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Contact Information: firstname.lastname@example.org +1(561)325-8757
Subscribe to our Free Newsletters!
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...
DOOR syndrome is a rare genetic disorder marked by deafness, short or absent fingernails, abnormal ...View All